Aastrom (ASTM) SPA for P3 Clinical Trial in No-Option CLI Patients
July 26th, 2011
No comments
ASTM preparing to begin P3 clinical trial in Q4/11 Read more…
Categories: Aastrom Biosciences, NASDAQ: ASTM, SPA Agreement
